Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

UBS Downgrades Molson Coor, Keurig Dr Pepper and Boston Beer as 'Normalization on the Horizon'

Published 21/06/2022, 21:14
Updated 21/06/2022, 21:14
© Reuters.

© Reuters.

By Sam Boughedda

UBS analyst Peter Grom, in a note to clients on Tuesday, downgraded Molson Coors (NYSE:TAP), Keurig Dr Pepper (NASDAQ:KDP), and Boston Beer Company (NYSE:SAM) to Neutral from Buy, stating that while they believe US beverages will deliver sustainable organic revenue outperformance in the longer-term, they see a normalization on the horizon as reopening catalysts dissipate.

“Our detailed bottom-up framework suggests that growth will become more differentiated across the group looking ahead and with Bevs having outperformed HPC by roughly 15% YTD and trading at a ~20% premium (vs. 5-yr avg. of +13%), we think investors should become selective within the group,” said Grom. “Our analysis suggests that KO, PEP, STZ, and CELH will see continue to see higher levels of organic revenue growth vs. peers and as such offer compelling risk/reward. We are moving to the sidelines on TAP, SAM, and KDP as we expect growth to moderate looking ahead.”

The analyst added that growth will be more differentiated across beverages beyond 2022.

“The degree to which on-premise occasions have returned to pre-pandemic levels varies by company, but our channel/category analysis suggests that most of this catch-up will be complete by the end of CY22, and we expect investors will focus on companies that can deliver outsized organic revenue growth LT,” added Grom.

“The return of on-premise has led to outsized growth for TAP, and while we believe in the company's LT strategy, we think moderating growth in '23E will make it difficult for the stock to re-rate. For SAM, we believe weaker-than-expected hard seltzer growth could drive downside to Street estimates. Finally, we view the KDP risk/reward as balanced at current levels and would wait for a more attractive entry point.”

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.